Abstract
Drug-excipient interactions in solid dosage forms can affect drug product stability in physical aspects such as organoleptic changes and dissolution slowdown, or chemically by causing drug degradation. Recent research has allowed the distinction in chemical instability resulting from direct drug-excipient interactions and from drug interactions with excipient impurities. A review of chemical instability in solid dosage forms highlights common mechanistic themes applicable to multiple degradation pathways. These common themes include the role of water and microenvironmental pH. In addition, special aspects of solid-state reactions with excipients and/or excipient impurities add to the complexity in understanding and modeling reaction pathways. This paper discusses mechanistic basis of known drug-excipient interactions with case studies and provides an overview of common underlying themes. Recent developments in the understanding of degradation pathways further impact methodologies used in the pharmaceutical industry for prospective stability assessment. This paper discusses these emerging aspects in terms of limitations of drug-excipient compatibility studies, emerging paradigms in accelerated stability testing, and application of mathematical modeling for prediction of drug product stability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Alu:
-
Aluminum
- API:
-
Active pharmaceutical ingredient
- ARP:
-
Amadori rearrangement product
- BHA:
-
Butylated hydroxyanisole
- BHT:
-
Butylated hydroxytoluene
- GC:
-
Gas chromatography
- HCl:
-
Hydrochloride
- HCTZ:
-
Hydrochlorothiazide
- HDPE:
-
High density polyethylene
- HPLC:
-
High performance liquid chromatography
- HPMC:
-
Hydroxypropyl methylcellulose
- HPO:
-
Hydroperoxide
- ICH:
-
International conference on harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
- LC/MS:
-
Liquid chromatography tandem with mass spectroscopy
- MVTR:
-
Moisture vapor transmission rate
- NF:
-
National Formulary
- NMR:
-
Nuclear magnetic resonance (spectroscopy)
- PEG:
-
Polyethylene glycol
- pHmax :
-
pH of maximum solubility
- PVA:
-
Polyvinyl alcohol
- PVP:
-
Polyvinyl pyrrolidone (povidone)
- PhEur:
-
European Pharmacopeia
- PVP-VA:
-
Polyvinylpyrrolidone-vinyl acetate copolymer
- PXRD:
-
Powder X-ray diffraction
- SDMT:
-
Sorption desorption moisture transfer
- ssNMR:
-
Solid state NMR
- USP:
-
United States Pharmacopeia
References
Abdoh A, Al-Omari MM, Badwan AA, Jaber AM (2004) Amlodipine besylate-excipients interaction in solid dosage form. Pharm Dev Technol 9(1):15–24
Ahlneck C, Alderborn G (1988) Solid state stability of acetylsalicylic acid in binary mixtures with microcrystalline and microfine cellulose. Acta Pharm Suec 25(1):41–52
Ahlneck C, Zografi G (1990) The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 62(2–3):87–95
Ahlneck C, Waltersson J-O, Lundgren P (1987) Difference in effect of powdered and granular magnesium stearate on the solid state stability of acetylsalicylic acid. Acta Pharmaceutica Technologica 33(1):21–26
Airaksinen S, Karjalainen M, Kivikero N, Westermarck S, Shevchenko A, Rantanen J, Yliruusi J (2005) Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation. AAPS PharmSciTech 6(2):E311–E322
Akiyama Y, Yoshioka M, Horibe H, Hirai S, Kitamori N, Toguchi H (1994) pH-independent controlled-release microspheres using polyglycerol esters of fatty acids. J Pharm Sci 83(11):1600–1607
Al-Nimry SS, Assaf SM, Jalal IM, Najib NM (1997) Adsorption of ketotifen onto some pharmaceutical excipients. Int J Pharm 149(1):115–121
Antipas AS, Landis MS (2005) Solid-state excipient compatibility testing. In: Antipas AS, Landis MS (eds) Drugs and the pharmaceutical sciences, vol 153. Taylor and Francis Group, LLC, pp 419–458
Ashraf-Khorassani M, Taylor LT, Waterman KC, Narayan P, Brannegan DR, Reid GL (2005) Purification of pharmaceutical excipients with supercritical fluid extraction. Pharm Dev Technol 10(4):507–516
Aso Y, Sufang T, Yoshioka S, Kojima S (1997) Amount of mobile water estimated from 2H spin-lattice relaxation time, and its effects on the stability of cephalothin in mixtures with pharmaceutical excipients. Drug Stab 1(4):237–242
Badawy SI (2001) Effect of salt form on chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms. Int J Pharm 223(1–2):81–87
Badawy SI, Hussain MA (2007) Microenvironmental pH modulation in solid dosage forms. J Pharm Sci 96(5):948–959
Badawy SI, Williams RC, Gilbert DL (1999) Effect of different acids on solid-state stability of an ester prodrug of a IIb/IIIa glycoprotein receptor antagonist. Pharm Dev Technol 4(3):325–331
Badawy SI, Gawronski AJ, Alvarez FJ (2001) Application of sorption-desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations. Int J Pharm 223(1–2):1–13
Badawy S, Vickery R, Shah K, Hussain M (2004) Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate. Pharm Dev Technol 9(3):239–245
Badawy SI, Gray DB, Zhao F, Sun D, Schuster AE, Hussain MA (2006) Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389. Pharm Res 23(5):989–996
Ballard JM, Zhu L, Nelson ED, Seburg RA (2007) Degradation of vitamin D3 in a stressed formulation: the identification of esters of vitamin D3 formed by a transesterification with triglycerides. J Pharm Biomed Anal 43(1):142–150
Bharate SS, Bharate SB, Bajaj AN (2010) Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excip Food Chem 1(3):3–26
Bindra DS, Williams TD, Stella VJ (1994) Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG 400. Pharm Res 11(7):1060–1064
Blaug SM, Wesolowski JW (1959) The stability of acetylsalicylic acid in suspension. J Am Pharm Assoc 48:691–694
Bonfilio R, Pires SA, Ferreira LMB, de Almeida AE, Doriguetto AC, de Araujo MB, Salgado HRN (2012) A discriminating dissolution method for glimepiride polymorphs. J Pharm Sci 101(2): 794–804
Botha SA, Lotter AP (1990) Compatibility study between naproxen and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm 16:673–683
Bruce LD, Shah NH, Waseem Malick A, Infeld MH, McGinity JW (2005) Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Eur J Pharm Biopharm 59(1):85–97
Buhler V (2008) Kollidon: polyvinylpyrrolidone excipients for the pharmaceuticals. Springer, Germany
Buhler V, Filges U, Schneider T (2000) Stabilized polyvinylpyrrolidone formulation. WO Patent 2000059478
Bundgaard H, Larsen C (1978) Kinetics and mechanism of the sucrose-accelerated degradation of penicillins in aqueous solution. Int J Pharm 1(2):95–104
Bundgaard H, Larsen C (1979) Piperazinedione formation from reaction of ampicillin with carbohydrates and alcohols in aqueous solution. Int J Pharm 3(1):1–11
Bundgaard H, Larsen C (1983) The influence of carbohydrates and polyhydric alcohols on the stability of cephalosporins in aqueous solution. Int J Pharm 16(3):319–325
Burghart W, Burghart K, Raneburger J (2004) Solid formulation of levothyroxine and/or liothyronine salts containing controlled amount of water for stability
Carstensen JT, Attarchi F (1988) Decomposition of aspirin in the solid state in the presence of limited amounts of moisture II: kinetics and salting-in of aspirin in aqueous acetic acid solutions. J Pharm Sci 77(4):314–317
Carstensen JT, Kothari RC (1980) Decarboxylation kinetics of 5-(tetradecyloxy)-2-furoic acid. J Pharm Sci 69(1):123–124
Carstensen JT, Musa MN (1972) Decomposition of benzoic acid derivatives in solid state. J Pharm Sci 61(7):1112–1118
Carstensen JT, Osadca M, Rubin SH (1969) Degradation mechanisms for water-soluble drugs in solid dosage forms. J Pharm Sci 58(5):549–553
Carvalho T, Rao V, Levons J, Wu J, Narang A, Paruchuri S, Stamato H, Varia S, Hemenway J (2011) Formation of reactive impurities in PEG 400 and effects of antioxidants and oxidation inducers on the reaction rates. Paper presented at the American Association of Pharmaceutical Sciences Annual Meeting, Washington, DC
Chen Y, Li Y (2003) A new model for predicting moisture uptake by packaged solid pharmaceuticals. Int J Pharm 255(1–2):217–225
Chien YW, Van Nostrand P, Hurwitz AR, Shami EG (1981) Drug-disintegrant interactions: binding of oxymorphone derivatives. J Pharm Sci 70(6):709–710
Claudius JS, Neau SH (1998) The solution stability of vancomycin in the presence and absence of sodium carboxymethyl starch. Int J Pharm 168(1):41–48
Cory W, Field K, Wu-Linhares D (2004) Is it the method or the process-separating the causes of low recovery. Drug Dev Ind Pharm 30(8):891–899
Crowley P, Martini L (2001) Drug-excipient interactions. Pharm Technol Europe 13(3):26–28, 30–32, 34
D’Souza AJ, Schowen RL, Borchardt RT, Salsbury JS, Munson EJ, Topp EM (2003) Reaction of a peptide with polyvinylpyrrolidone in the solid state. J Pharm Sci 92(3):585–593
De Ritter E, Magid L, Osadca M, Rubin SH (1970) Effect of silica gel on stability and biological availability of ascorbic acid. J Pharm Sci 59(2):229–232
del Barrio MA, Hu J, Zhou P, Cauchon N (2006) Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC/MS. J Pharm Biomed Anal 41(3):738–743
Desai DS, Rubitski BA, Bergum JS, Varia SA (1994a) Effects of different types of lactose and disintegrant on dissolution stability of hydrochlorothiazide capsule formulations. Int J Pharm 110(3):257–265
Desai DS, Rubitski BA, Bergum JS, Varia SA (1994b) Effects of different types of lactose and disintegrant on dissolution stability of hydrochlorothiazide capsule formulations. Int J Pharm 110(3):257–265
Desai DS, Rubitski BA, Varia SA, Huang MH (1994c) Effect of formaldehyde formation on dissolution stability of hydrochlorothiazide bead formulations. Int J Pharm 107(2):141–147
Desai DS, Ranadive SA, Lozano R, Varia SA (1996) Dissolution instability of encapsulated marketed tablets. Int J Pharm 144(2):153–158
Desai SR, Shaikh MM, Dharwadkar SR (2003) Preformulation compatibility studies of etamsylate and fluconazole drugs with lactose by DSC. J Therm Anal Calorim 71(2):651–658
Desai D, Rao V, Guo H, Li D, Bolgar M (2007) Stability of low concentrations of guanine-based antivirals in sucrose or maltitol solutions. Int J Pharm 342(1–2):87–94
Devani MB, Shishoo CJ, Doshi KJ, Patel HB (1985) Kinetic studies of the interaction between isoniazid and reducing sugars. J Pharm Sci 74(4):427–432
Dey M, Enever R, Kraml M, Prue DG, Smith D, Weierstall R (1993) The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures. Pharm Res 10(9):1295–1300
Dickinson CF, Heal GR (1999) Solid-liquid diffusion controlled rate equations. Thermochim Acta 340–341:89–103
Digenis GA, Gold TB, Shah VP (1994a) Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 83(7):915–921
Digenis GA, Gold TB, Shah VP (1994b) Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 83(7):915–921
Digenis GA, Sandefer EP, Page RC, Doll WJ, Gold TB, Darwazeh NB (2000) Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture. Pharm Res 17(5):572–582
Doherty C, York P (1989) The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions. J Pharm Pharmacol 41(2):73–78
Dubost DC, Kaufman MJ, Zimmerman JA, Bogusky MJ, Coddington AB, Pitzenberger SM (1996) Characterization of a solid state reaction product from a lyophilized formulation of a cyclic heptapeptide. A novel example of an excipient-induced oxidation. Pharm Res 13(12):1811–1814
Durig T, Fassihi AR (1993) Identification of stabilizing and destabilizing effects of excipient-drug interactions in solid-dosage form design. Int J Pharm 97:161–170
EMEAguidance (2008) EMEA Guide line on the specification limits for residues of metal catalysts or metal reagents Doc. Ref. EMEA/CHMP/SWP/4446/2000. London
Fereira PJ, Desjardin MA, Rohloff CM, Berry SA, Zlatkova-Karaslavova ES (2005) Non-aqueous formulations containing biodegradable polymers and methionine and solvents for removing peroxides and reducing the oxidative degradation of drugs. US Patent 2005276856
Fielden KE, Newton JM, O’Brien P, Rowe RC (1988) Thermal studies on the interaction of water and microcrystalline cellulose. J Pharm Pharmacol 40(10):674–678
Fitzpatrick S, McCabe JF, Petts CR, Booth SW (2002) Effect of moisture on polyvinylpyrrolidone in accelerated stability testing. Int J Pharm 246(1–2):143–151
Forni F, Coppi G, Iannuccelli V, Vandelli MA, Cameroni R (1988) The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica. Acta Pharmaceutica Suecica 25(3):173–180
Fukuyama S, Kihara N, Naksashima K, Morokoshi N, Koda S, Yasuda T (1994) Mechanism of optical isomerization of (S)-N-[1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo[3,2,1-jk][1,4]-benzodiazepine-3-yl]-1H-indole-2-carboxamide (FK480) in soft capsules containing polyethylene glycol 400 and glycerol. Pharm Res 11(12):1704–1706
Fukuyama S, Kihara N, Nakashima K, Morokoshi N, Koda S, Yasuda T (1996) Mechanism and suppression of optical isomerization of FK 480 in soft capsules containing polyethylene glycol 400 and glycerol. Drug Stab 1(2):128–131
Gabr KE (1992) Effect of organic acids on the release patterns of weakly basic drugs from inert sustained-release matrix tablets. Eur J Pharm Biopharm 38(6):199–202
George RC (1994) Investigation into the yellowing on aging of Sabril tablet cores. Drug Dev Ind Pharm 20(19):3023–3032
Glastrup J (1996) Degradation of polyethylene glycol. A study of the reaction mechanism in a model molecule: tetraethylene glycol. Polym Degrad Stab 52(3):217–222
Glombitza BW, Oelkrug D, Schmidt PC (1994) Surface acidity of solid pharmaceutical excipients. Part 1. Determination of the surface acidity. Eur J Pharm Biopharm 40(5):289–293
Gordon MS, Rudraraju VS, Rhie JK, Chowhan ZT (1993) The effect of aging on the dissolution of wet granulated tablets containing super disintegrants. Int J Pharm 97(1–3):119–131
Gore AY, Banker GS (1979) Surface chemistry of colloidal silica and a possible application to stabilize aspirin in solid matrixes. J Pharm Sci 68(2):197–202
Gu L, Strickley RG, Chi LH, Chowhan ZT (1990) Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: dry powder vs wet granulation. Pharm Res 7(4):379–383
Guerrieri P, Taylor LS (2009) Role of salt and excipient properties on disproportionation in the solid-state. Pharm Res 26(8):2015–2026
Hancock BC, Zografi G (1994) The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm Res 11(4):471–477
Hartauer KJ, Arbuthnot GN, Baertschi SW, Johnson RA, Luke WD, Pearson NG, Rickard EC, Tingle CA, Tsang PK, Wiens RE (2000a) Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product. Pharm Dev Technol 5(3):303–310
Hartauer KJ, Arbuthnot GN, Baertschi SW, Johnson RA, Luke WD, Pearson NG, Rickard EC, Tingle CA, Tsang PK, Wiens RE (2000b) Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product. Pharm Dev Technol 5(3):303–310
Hartley RF, Huang Y, Cassidy M, Razler TM, Qian F, Hussain MA (2011) The degradation kinetics and mechanism of an oxadiazole derivative, a g-secretase inhibitor drug candidate. J Pharm Sci (Submitted)
Hasegawa J, Hanano M, Awazu S (1975) Decomposition of acetylsalicylic acid and its derivatives in solid state. Chem Pharm Bull (Tokyo) 23:86–97
Heidemann DR, Jarosz PJ (1991) Preformulation studies involving moisture uptake in solid dosage forms. Pharm Res 8(3):292–297
Hemenway J, Kirby S, Narang A, Rao V, Paruchuri S, Derbin G, Stamato H (2010) Effect of water activity and water absorption properties on the stability of film-coated tablet formulations of a moisture sensitive active pharmaceutical ingredient. Paper presented at the American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA
Hickey MB, Peterson ML, Manas ES, Alvarez J, Haeffner F, Almarsson O (2007) Hydrates and solid-state reactivity: a survey of b-lactam antibiotics. J Pharm Sci 96(5):1090–1099
Hong J, Lee E, Carter JC, Masse JA, Oksanen DA (2004) Antioxidant-accelerated oxidative degradation: a case study of transition metal ion catalyzed oxidation in formulation. Pharm Dev Technol 9(2):171–179
Huffman RW, Donzel A, Bruice TC (1967) Aminolysis of esters. VII. The reaction of lysine with phenyl acetate and triacetin. J Org Chem 32(6):1973–1976
ICH Q3A: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2000a) Draft revised guidance on impurities in new drug products. Q3B(R). http://www.ich.org/products/guidelines/quality/quality-single/article/impurities-in-new-drug-products.html. Accessed July 2015
ICHQ3B: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2000b) Draft revised guidance on impurities in new drug substances. Q3A. http://www.ich.org/products/guidelines/quality/quality-single/article/impurities-in-new-drug-products.html. Accessed July 2015
ICH Q3C: International Conferences on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (1997) Impurities: guidelines for residual solvents. Q3C. http://www.ich.org/products/guidelines/quality/quality-single/article/impurities-guideline-for-residual-solvents.html. Accessed July 2015
ICH Q1E: International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2004) Guidance for industry: Q1E evaluation of stability data. http://www.ich.org/products/guidelines/quality/quality-single/article/evaluation-of-stability-data.html. Accessed July 2015
Irwin WJ, Iqbal M (1991) Solid-state stability: the effect of grinding solvated excipients. Int J Pharm 75(2–3):211–218
Jander W (1927) Reaction in the solid state at high temperature. I. Rate of reaction for an endothermic change. Zeitschrift fuer Anorganische und Allgemeine Chemie 163:1–30
Janicki CA, Almond HR Jr (1974) Reaction of haloperidol with 5-(hydroxymethyl)-2-furfuraldehyde, an impurity in anhydrous lactose. J Pharm Sci 63(1):41–43
Johansen H, Moller N (1977) Solvent deposition of drugs on excipients II: interpretation of dissolution, adsorption, and absorption charcteristics of drugs. Arch Pharm Chem (Sci) 5:33–42
Kararli TT, Needham TE, Seul CJ, Finnegan PM (1989) Solid-state interaction of magnesium oxide and ibuprofen to form a salt. Pharm Res 6(9):804–808
Khan S, Giradkar P, Yeole P (2009) Formulation design of ranitidine hydrochloride to reduce its moisture absorption characteristics. PDA J Pharm Sci Technol 63(3):226–233
Khawam A, Flanagan DR (2005) Complementary use of model-free and modelistic methods in the analysis of solid-state kinetics. J Phys Chem B 109(20):10073–10080
Khawam A, Flanagan DR (2006) Basics and applications of solid-state kinetics: a pharmaceutical perspective. J Pharm Sci 95(3):472–498
Killion RB Jr, Stella VJ (1990a) The nucleophilicity of dextrose, sucrose, sorbitol, and mannitol with p-nitrophenyl esters in aqueous solution. Int J Pharm 66(1–3):149–155
Killion RB, Stella VJ (1990b) The nucleophilicity of dextrose, sucrose, sorbitol, and mannitol with p-nitrophenyl esters in aqueous solution. Int J Pharm 66(1–3):149–155
Kitamura S, Miyamae A, Koda S, Morimoto Y (1989) Effect of grinding on the solid-state stability of cefixime trihydrate. Int J Pharm 56(2):125–134
Konishi M, Hirai K, Mori Y (1982) Kinetics and mechanism of the equilibrium reaction of triazolam in aqueous solution. J Pharm Sci 71(12):1328–1334
Kontny MJ (1988) Distribution of water in solid pharmaceutical systems. Drug Dev Ind Pharm 14(14):1991–2027
Kontny MJ, Koppenol S, Graham ET (1992) Use of the sorption-desorption moisture transfer model to assess the utility of a desiccant in a solid product. Int J Pharm 84(3):261–271
Kornblum SS, Sciarrone BJ (1964) Decarboxylation of P-aminosalicylic acid in the solid state. J Pharm Sci 53:935–941
Kothari S, Paruchuri S, Rao V, Desai D (2006) Peroxide scavenging property of croscarmellose sodium and its potential to reduce N-oxidation of piperazine ring containing compounds. Paper presented at the American Association of Pharmaceutical Scientists, San Antonio, TX
Ku MS, Lu Q, Li W, Chen Y (2011) Performance qualification of a new hypromellose capsule: part II. Disintegration and dissolution comparison between two types of hypromellose capsules. Int J Pharm 416(1):16–24
Kumar V, Kalonia Devendra S (2006) Removal of peroxides in polyethylene glycols by vacuum drying: implications in the stability of biotech and pharmaceutical formulations. AAPS PharmSciTech 7(3):62
Larsen J, Cornett C, Jaroszewski JW, Hansen SH (2009) Reaction between drug substances and pharmaceutical excipients: formation of citric acid esters and amides of carvedilol in the solid state. J Pharm Biomed Anal 49(1):11–17
Lessen T, Zhao DC (1996) Interactions between drug substances and excipients. 1. Fluorescence and HPLC studies of triazolophthalazine derivatives from hydralazine hydrochloride and starch. J Pharm Sci 85(3):326–329
Li S, Patapoff TW, Overcashier D, Hsu C, Nguyen TH, Borchardt RT (1996) Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state. J Pharm Sci 85(8):873–877
Mahato RI, Narang AS (2011) Pharmaceutical dosage forms and drug delivery, 2nd edn. CRC Press, Boca Raton
March J (1992) Advanced organic chemistry: reactions, mechanisms, and structure, 4th edn, ÂWiley, New York
Mauger JW, Paruta AN, Gerraughty RJ (1969) Consecutive first-order kinetic consideration of hydrocortisone hemisuccinate. J Pharm Sci 58(5):574–578
Meyer MC, Straughn AB, Mhatre RM, Hussain A, Shah VP, Bottom CB, Cole ET, Lesko LL, Mallinowski H, Williams RL (2000) The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Pharm Res 17(8):962–966
Mollica J, Rehm C, Smith J (1969) Hydrolysis of hydrochlorotiazide. J Pharm Sci 58:1380–1384
Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson T, Roberts MS (2009a) Assessment of feasibility of Maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre formulation studies. AAPS PharmSciTech 10(2):649–659
Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson TA, Roberts MS (2009b) Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. Eur J Pharm Biopharm 73(3):404–413
Murthy KS, Ghebre-Sellassie I (1993) Current perspectives on the dissolution stability of solid oral dosage forms. J Pharm Sci 82(2):113–126
Murugesan R, Kaimulankara G, Pillai SRS (2007) A novel pharmaceutical composition. IN Patent 2005-CH990
Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S (2007) Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac. Arch Pharm Res 30(2):222–234
Narang AS, Rao VM, Raghavan K (2009) Excipient compatibility. In: Qiu Y, Chen Y, Zhang GGZ, Liu L, Porter W (eds) Developing solid oral dosage forms: pharmaceutical theory and practice. Elsevier, Burlington, pp 125–146
Narang AS, Lin J, Varia SA, Badawy S (2010a) Modeling drug degradation in a tablet. Paper presented at the American Association of Pharmaceutical Sciences Annual Meeting, New Orleans, LA
Narang AS, Rao V, Farrell T, Ferrizzi D, Castoro J, Corredor C, Jain N, Varia S, Desai D (2010b) Stability implications of prolonged storage of PVA and PEG-based coating suspension. Paper presented at the American Association of Pharmaceutical Sciences Annual Meeting, New Orleans, LA
Narang A, Kanthasamy M, Castoro J, Varia S, Desai D (2011) Effect of pro- and anti-oxidants on the formation of formyl species in PVA- and PEG-based tablet coating material. Paper presented at the American Association of Pharmaceutical Sciences Annual Meeting, Washington, DC
Narang AS, Rao VM, Desai DS (2012) Effect of antioxidants and silicates on peroxides in povidone. J Pharm Sci 101(1):127–139
Nassar MN, Nesarikar VN, Lozano R, Parker WL, Huang Y, Palaniswamy V, Xu W, Khaselev N (2004) Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product. Pharm Dev Technol 9(2):189–195
Naversnik K, Bohanec S (2008) Predicting drug hydrolysis based on moisture uptake in various packaging designs. Eur J Pharm Sci 35(5):447–456
Nishikawa M, Fujii K (1991) Effect of autoxidation of hydrogenated castor oil containing 60 oxyethylene groups on degradation of miconazole. Chem Pharm Bull 39(9):2408–2411
Patel NK, Patel IJ, Cutie AJ, Wadke DA, Monkhouse DC, Reier GE (1988) The effect of selected direct compression excipients on the stability of aspirin as a model hydrolyzable drug. Drug Dev Ind Pharm 14(1):77–98
Perrier PR, Kesselring UW (1983) Quantitative assessment of the effect of some excipients on nitrazepam stability in binary powder mixtures. J Pharm Sci 72(9):1072–1074
Phadnis NV, Suryanarayanan R (1997) Polymorphism in anhydrous theophylline-implications on the dissolution rate of theophylline tablets. J Pharm Sci 86(11):1256–1263
Plackett RL, Burman JP (1946) The design of optimum multifactorial experiments. Biometrika 33:305–325
Podczeck F, Jones BE (2002) The in vitro dissolution of theophylline from different types of hard shell capsules. Drug Dev Ind Pharm 28(9):1163–1169
Qiu Z, Stowell JG, Cao W, Morris KR, Byrn SR, Carvajal MT (2005) Effect of milling and compression on the solid-state Maillard reaction. J Pharm Sci 94(11):2568–2580
Reed RA, Harmon P, Manas D, Wasylaschuk W, Galli C, Biddell R, Bergquist PA, Hunke W, Templeton AC, Ip D (2003) The role of excipients and package components in the photostability of liquid formulations. PDA J Pharm Sci Technol 57(5):351–368
Rivera SL, Ghodbane S (1994) In vitro adsorption-desorption of famotidine on microcrystalline cellulose. Int J Pharm 108(1):31–38
Rohrs BR, Thamann TJ, Gao P, Stelzer DJ, Bergren MS, Chao RS (1999) Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharm Res 16(12):1850–1856
Rowe RC, Forse SF (1983) Pitting: a defect on film coated tablets. Int J Pharm 17(2–3):347–349
Rowe RC, Sheskey PJ, Weller PJ, Rowe R, Sheskey P, Weller P (2003) Handbook of pharmaceutical excipients, 4th edn. APhA Publications, Pharmaceutical Press, London, UK
Roy J (2002) Pharmaceutical impurities—a mini review. AAPS PharmSciTech 3(2):1–8
Sakharov AM, Mazaletskaya LI, Skibida IP (2001) Catalytic oxidative deformylation of polyethylene glycols with the participation of molecular oxygen. Kinet Catal 42(5):662–668
Santos AFO, Basilio ID Jr, Souza FS, Medeiros AFD, Ferraz Pinto M, Santana DP, Macedo RO (2008) Application of thermal analysis in study of binary mixtures with metformin. J Therm Anal Calorim 93(2):361–364
Sarisuta N, Lawanprasert P, Puttipipatkhachorn S, Srikummoon K (2006) The influence of drug-excipient and drug-polymer interactions on butt adhesive strength of ranitidine hydrochloride film-coated tablets. Drug Dev Ind Pharm 32(4):463–471
Schildcrout SA, Risley DS, Kleemann RL (1993) Drug-excipient interactions of seproxetine maleate hemihydrate: isothermal stress methods. Drug Dev Ind Pharm 19(10):1113–1130
Senderoff RI, Mahjour M, Radebaugh GW (1982) Characterization of adsorption behavior by solid dosage form excipients in formulation development. Int J Pharm 83(1–3):65–72
Shalaev EY, Zografi G (1996) How does residual water affect the solid-state degradation of drugs in the amorphous state? J Pharm Sci 85(11):1137–1141
Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K (2010) Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules. Int J Pharm 386(1–2):30–41
Siepmann JI, Martin MG, Chen B, Stubbs JM, Potoff JJ (2000) Monte Carlo simulations of supercritical fluid extraction systems. Abstracts of Papers, 220th ACS National Meeting, Washington, DC, United States, August 20–24, 2000 FIELD Full Journal Title: Abstracts of Papers, 220th ACS National Meeting, Washington, DC, United States, August 20–24, 2000:COMP-143
Sinclair W, Leane M, Clarke G, Dennis A, Tobyn M, Timmins P (2011) Physical stability and recrystallization kinetics of amorphous ibipinabant drug product by fourier transform Raman spectroscopy. J Pharm Sci 100(11):4687–4699
Snider B, Liang P, Pearson N (2007) Implementation of water-activity testing to replace Karl Fischer water testing for solid oral-dosage forms. Pharm Technol 31(2):56, 58, 60, 62, 64–66, 68, 70–71
Stanisz B (2005) The influence of pharmaceutical excipients on quinapril hydrochloride stability. Acta Pol Pharm 62(3):189–193
Stephenson GA, Aburub A, Woods TA (2011) Physical stability of salts of weak bases in the solid-state. J Pharm Sci 100(5):1607–1617
Streubel A, Siepmann J, Dashevsky A, Bodmeier R (2000) pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J Control Release 67(1):101–110
Swaminathan V, Kildsig DO (2001) An examination of the moisture sorption characteristics of commercial magnesium stearate. AAPS PharmSciTech 2(4):28
Tallon MA, Malawer EG, Machnicki NI, Brush PJ, Wu CS, Cullen JP (2008) The effect of crosslinker structure upon the rate of hydroperoxide formation in dried, crosslinked poly(vinylpyrrolidone). J Appl Polym Sci 107(5):2776–2785
Tantry JS, Tank J, Suryanarayanan R (2007) Processing-induced phase transitions of theophylline-implications on the dissolution of theophylline tablets. J Pharm Sci 96(5):1434–1444
Tardif R (1965) Reliability of accelerated storage tests to predict stability of vitamins (A, B-1, C) in tablets. J Pharm Sci 54:281–284
Tatavarti AS, Mehta KA, Augsburger LL, Hoag SW (2004) Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J Pharm Sci 93(9):2319–2331
Thakur AB, Morris K, Grosso JA, Himes K, Thottathil JK, Jerzewski RL, Wadke DA, Carstensen JT (1993) Mechanism and kinetics of metal ion-mediated degradation of fosinopril sodium. Pharm Res 10(6):800–809
Tischinger-Wagner H, Endres W, Rupprecht H, Weingart A (1987) [Oxidative degradation of linoleic acid methyl ester in suspensions of inorganic excipients. 1. Auto-oxidation in the presence of silicic acid products and aluminum oxide]. Pharmazie 42(5):320–324
Tong P, Zografi G (2004) Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin. AAPS PharmSciTech 5(2):No pp given
Tuleu C, Khela MK, Evans DF, Jones BE, Nagata S, Basit AW (2007) A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules. Eur J Pharm Sci 30(3–4):251–255
Vyazovkin S, Wight CA (1997) Kinetics in solids. Annu Rev Phys Chem 48:125–149
Wang G, Fiske JD, Jennings SP, Tomasella FP, Palaniswamy VA, Ray KL (2008) Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation. Pharm Dev Technol 13(5):393–399
Wang J, Wen H, Desai D (2010) Lubrications in tablet formulations. Eur J Pharm Biopharm 75:1–15
Wasylaschuk WR, Harmon PA, Wagner G, Harman AB, Templeton AC, Xu H, Reed RA (2007a) Evaluation of hydroperoxides in common pharmaceutical excipients. J Pharm Sci 96(1):106–116
Wasylaschuk WR, Harmon PA, Wagner R, Wagner G, Harman AB, Tempelton AC, Xu H, Reed RA (2007b) Evaluation of hydroperoxides in common pharmaceutical excipients. J Pharm Sci 96(1):106–116
Waterman KC, Adami RC (2005) Accelerated aging: prediction of chemical stability of pharmaceuticals. Int J Pharm 293(1–2):101–125
Waterman KC, Macdonald BC (2010) Package selection for moisture protection for solid oral drug products. J Pharm Sci 99(11):4437–4452
Waterman KC, Adami RC, Alsante KM, Antipas AS, Arenson DR, Carrier R, Hong J, Landis MS, Lombardo F, Shah JC, Shalaev E, Smith SW, Wang H (2002a) Hydrolysis in pharmaceutical formulations. Pharm Dev Technol 7(2):113–146
Waterman KC, Adami RC, Alsante KM, Hong J, Landis MS, Lombardo F, Roberts CJ (2002b) Stabilization of pharmaceuticals to oxidative degradation. Pharm Dev Technol 7(1):1–32
Waterman KC, Arikpo WB, Fergione MB, Graul TW, Johnson BA, Macdonald BC, Roy MC, Timpano RJ (2008a) N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet. J Pharm Sci 97(4):1499–1507
Waterman KC, Gerst P, Macdonald BC (2011) Relative humidity hysteresis in solid-state chemical reactivity: a pharmaceutical case study. J Pharm Sci 101(2):610–615
Wirth DD, Baertschi SW, Johnson RA, Maple SR, Miller MS, Hallenbeck DK, Gregg SM (1998) Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. J Pharm Sci 87(1):31–39
Wong J, Wiseman L, Al-Mamoon S, Cooper T, Zhang LK, Chan TM (2006) Major degradation product identified in several pharmaceutical formulations against the common cold. Anal Chem 78(22):7891–7895
Wu Y, Dali M, Gupta A, Raghavan K (2009) Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form. Pharm Dev Technol 14(5):556–564
Wu Y, Levons J, Narang AS, Raghavan K, Rao VM (2011a) Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech 12(4):1248–1263
Wu Y, Levons J, Narang AS, Raghavan K, Rao VM (2011b) Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech (September)
Wyttenbach N, Birringer C, Alsenz J, Kuentz M (2005) Drug-excipient compatibility testing using a high-throughput approach and statistical design. Pharm Dev Technol 10(4):499–505
Yarkala S, Amaravadi S, Rao VU, Vijaykumar V, Navalgund SG, Jagdish B (2009) Role of excipients on N-oxide raloxifene generation from raloxifene-excipients binary mixtures. Chem Pharm Bull 57(10):1174–1177
Yoshioka S, Stella VJ (2000) Stability of drugs and dosage forms. Kluwer, New York
Yoshioka S, Uchiyama M (1986) Kinetics and mechanism of the solid-state decomposition of propantheline bromide. J Pharm Sci 75(1):92–96
Yoshioka S, Ogata H, Shibazaki T, Ejima A (1979) Stability of sulpyrine. V. Oxidation with molecular oxygen in the solid state. Chem Pharm Bull (Tokyo) 27:2363–2371
Yoshioka S, Shibazaki T, Eijima A (1983) Stability of solid dosage forms. II. Hydrolysis of meclofenoxate hydrochloride in commercial tablets. Chem Pharm Bull (Tokyo) 31:2513–2517
Yoshioka S, Aso Y, Shibazaki T, Uchiyama M (1986) Stability of pilocarpine ophthalmic formulations. Chem Pharm Bull (Tokyo) 34(10):4280–4286
Yoshioka S, Aso Y, Terao T (1992) Effect of water mobility on drug hydrolysis rates in gelatin gels. Pharm Res 9(5):607–612
Yu H, Cornett C, Larsen J, Hansen SH (2010) Reaction between drug substances and pharmaceutical excipients: formation of esters between cetirizine and polyols. J Pharm Biomed Anal 53(3):745–750
Yuan LC, Dahl TC, Oliyai R (2000) Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil. Pharm Res 17(9):1098–1103
Zannou EA, Ji Q, Joshi YM, Serajuddin AT (2007) Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form. Int J Pharm 337(1–2):210–218
Zhou D, Schmitt EA, Zhang GG, Law D, Wight CA, Vyazovkin S, Grant DJ (2003) Model-free treatment of the dehydration kinetics of nedocromil sodium trihydrate. J Pharm Sci 92(7):1367–1376
Acknowledgements
The majority of this chapter and illustrations are reprinted from Pharmaaceutical Research, Vol. 29 (© 2012) pp 2660–2683, with permission from Springer.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Narang, A., Desai, D., Badawy, S. (2015). Impact of Excipient Interactions on Solid Dosage Form Stability. In: Narang, A., Boddu, S. (eds) Excipient Applications in Formulation Design and Drug Delivery. Springer, Cham. https://doi.org/10.1007/978-3-319-20206-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-20206-8_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20205-1
Online ISBN: 978-3-319-20206-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)